Biotheus and Bitterroot Bio Join Forces for the Development of Bispecific Proteins in Cardio-Immunology
Shots:
- Bitterroot Bio has signed a multi-year research collaboration agreement with Biotheus to find innovative methods for modulating the immune system & inflammatory responses involved in the progression of various cardiovascular diseases
- The partnership will combine Bitterroot Bio's expertise in cardiovascular medicine & biology with Biotheus' ability of protein therapeutics designing to discover & develop therapies for atherosclerosis and other cardiovascular diseases
- The companies will conduct joint R&D to nominate product candidates for further development in preclinical & clinical programs
Ref: Globenewswire | Image: Biotheus
Related News:- Biotheus Collaborates with BioNTech for the Development and Commercialization of PM8002 to Treat Multiple Solid Tumor Indications
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
Click here to read the full press release
Tags
Disha is a content writer at PharmaShots. She is passionate and curious about recent updates and developments in MedTech and Pharma industry. She covers news related to clinical trial results and updates. She can be contacted at connect@pharmashots.com.
